Cambridge Investment Research Advisors Inc. Sells 119 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Cambridge Investment Research Advisors Inc. lessened its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 4.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,296 shares of the medical instruments supplier’s stock after selling 119 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in Mesa Laboratories were worth $272,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently bought and sold shares of MLAB. Amundi grew its stake in shares of Mesa Laboratories by 81.6% during the 4th quarter. Amundi now owns 661 shares of the medical instruments supplier’s stock worth $91,000 after acquiring an additional 297 shares during the period. Resona Asset Management Co. Ltd. bought a new position in Mesa Laboratories in the 4th quarter worth about $92,000. KLP Kapitalforvaltning AS bought a new position in Mesa Laboratories in the 4th quarter worth about $132,000. Tower Research Capital LLC TRC boosted its stake in Mesa Laboratories by 72.9% in the 4th quarter. Tower Research Capital LLC TRC now owns 1,328 shares of the medical instruments supplier’s stock worth $175,000 after purchasing an additional 560 shares during the period. Finally, ProShare Advisors LLC bought a new position in Mesa Laboratories in the 4th quarter worth about $205,000. Institutional investors own 90.60% of the company’s stock.

Mesa Laboratories Stock Performance

NASDAQ:MLAB opened at $86.42 on Friday. The business has a 50 day moving average of $104.95 and a 200 day moving average of $121.32. The company has a market capitalization of $471.85 million, a price-to-earnings ratio of -233.57 and a beta of 0.86. Mesa Laboratories, Inc. has a 1-year low of $86.27 and a 1-year high of $155.12. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.63 and a quick ratio of 0.47.

Mesa Laboratories Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, September 15th. Shareholders of record on Friday, August 29th will be paid a $0.16 dividend. The ex-dividend date of this dividend is Friday, August 29th. This represents a $0.64 dividend on an annualized basis and a yield of 0.74%. Mesa Laboratories’s dividend payout ratio (DPR) is currently -172.97%.

Insiders Place Their Bets

In other Mesa Laboratories news, CFO John Sakys sold 642 shares of Mesa Laboratories stock in a transaction that occurred on Monday, June 16th. The stock was sold at an average price of $97.12, for a total value of $62,351.04. Following the transaction, the chief financial officer directly owned 12,865 shares of the company’s stock, valued at $1,249,448.80. The trade was a 4.75% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Brian David Archbold sold 472 shares of Mesa Laboratories stock in a transaction that occurred on Monday, June 16th. The stock was sold at an average price of $97.12, for a total value of $45,840.64. Following the completion of the transaction, the senior vice president directly owned 558 shares in the company, valued at $54,192.96. This trade represents a 45.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 3,053 shares of company stock valued at $296,507 in the last ninety days. Company insiders own 4.40% of the company’s stock.

Analyst Upgrades and Downgrades

MLAB has been the subject of several analyst reports. Wells Fargo & Company cut their target price on Mesa Laboratories from $120.00 to $100.00 and set an “underweight” rating for the company in a research note on Friday, May 30th. Wall Street Zen downgraded Mesa Laboratories from a “strong-buy” rating to a “buy” rating in a research note on Friday, May 30th.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.